Indrajit Karmakar

486 total citations
20 papers, 394 citations indexed

About

Indrajit Karmakar is a scholar working on Pharmacology, Biochemistry and Plant Science. According to data from OpenAlex, Indrajit Karmakar has authored 20 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Biochemistry and 5 papers in Plant Science. Recurrent topics in Indrajit Karmakar's work include Phytochemicals and Antioxidant Activities (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Phytochemistry and Bioactivity Studies (3 papers). Indrajit Karmakar is often cited by papers focused on Phytochemicals and Antioxidant Activities (6 papers), Pharmacological Effects of Natural Compounds (5 papers) and Phytochemistry and Bioactivity Studies (3 papers). Indrajit Karmakar collaborates with scholars based in India and United States. Indrajit Karmakar's co-authors include Pallab Kanti Haldar, Asis Bala, Biswakanth Kar, Narayan Dolai, Mainak Chakraborty, Sanjib Bhattacharya, Upal Kanti Mazumder, Saikat Dewanjee, Dilshad Ahmad and Pallab Kanti Haldar and has published in prestigious journals such as Journal of Ethnopharmacology, Pharmaceutical Biology and Asian Pacific Journal of Tropical Biomedicine.

In The Last Decade

Indrajit Karmakar

18 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indrajit Karmakar India 11 158 121 99 70 64 20 394
Narayan Dolai India 11 130 0.8× 129 1.1× 67 0.7× 83 1.2× 52 0.8× 21 356
Tsu-Liang Chang Taiwan 10 128 0.8× 161 1.3× 100 1.0× 107 1.5× 40 0.6× 16 472
Mohd Mujeeb India 11 156 1.0× 131 1.1× 61 0.6× 80 1.1× 83 1.3× 30 419
Diorge Jônatas Marmitt Brazil 9 128 0.8× 146 1.2× 66 0.7× 51 0.7× 56 0.9× 31 359
Suresh V. Nampoothiri India 9 146 0.9× 59 0.5× 108 1.1× 93 1.3× 78 1.2× 14 383
Nianwu He China 8 206 1.3× 183 1.5× 120 1.2× 61 0.9× 42 0.7× 14 574
Vijayasteltar Belsamma Liju India 11 108 0.7× 112 0.9× 121 1.2× 144 2.1× 56 0.9× 15 443
Marina Gálvez Spain 5 152 1.0× 164 1.4× 63 0.6× 32 0.5× 33 0.5× 6 337
Patrick Nwabueze Okechukwu Malaysia 15 114 0.7× 189 1.6× 77 0.8× 56 0.8× 44 0.7× 48 522
Thiam Tsui Tee Malaysia 8 76 0.5× 211 1.7× 43 0.4× 47 0.7× 39 0.6× 11 385

Countries citing papers authored by Indrajit Karmakar

Since Specialization
Citations

This map shows the geographic impact of Indrajit Karmakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indrajit Karmakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indrajit Karmakar more than expected).

Fields of papers citing papers by Indrajit Karmakar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indrajit Karmakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indrajit Karmakar. The network helps show where Indrajit Karmakar may publish in the future.

Co-authorship network of co-authors of Indrajit Karmakar

This figure shows the co-authorship network connecting the top 25 collaborators of Indrajit Karmakar. A scholar is included among the top collaborators of Indrajit Karmakar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indrajit Karmakar. Indrajit Karmakar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Karmakar, Indrajit, et al.. (2016). In vitro antioxidant and cytotoxic activity of Zanthonitrile isolated from Zanthoxylum alatum. Journal of Applied Pharmaceutical Science. 119–122. 5 indexed citations
3.
Chakraborty, Mainak, et al.. (2015). ANTICANCER AND ANTIOXIDANT ACTIVITY OF METHANOL EXTRACT OF HIPPOPHAE SALICIFOLIA IN EAC INDUCED SWISS ALBINO MICE. International Journal of Pharmacy and Pharmaceutical Sciences. 8(8). 180–184. 10 indexed citations
4.
Karmakar, Indrajit, et al.. (2015). Regulation of apoptosis through bcl-2/bax proteins expression and DNA damage byZanthoxylum alatum. Pharmaceutical Biology. 54(3). 503–508. 25 indexed citations
5.
Karmakar, Indrajit, et al.. (2015). Antitumor Potential of Thevetia peruviana on Ehrlich's Ascites Carcinoma-Bearing Mice. Journal of Environmental Pathology Toxicology and Oncology. 34(2). 105–113. 13 indexed citations
6.
Karmakar, Indrajit, et al.. (2015). Preclinical assessment of Cascabela thevetia fruits on developmental toxicity and behavioral safety in zebrafish embryos. Oriental Pharmacy and Experimental Medicine. 15(4). 371–377. 9 indexed citations
7.
Bala, Asis, et al.. (2015). Amelioration of oxidative DNA damage in mouse peritoneal macrophages by Hippophae salicifolia due to its proton (H+) donation capability: Ex vivo and in vivo studies. Journal of Pharmacy And Bioallied Sciences. 8(3). 210–210. 5 indexed citations
8.
Kar, Biswakanth, et al.. (2015). Antitumor activity and antioxidant status of Streblus asper bark against Dalton's ascitic lymphoma in mice. Interdisciplinary Toxicology. 8(3). 125–130. 12 indexed citations
9.
Karmakar, Indrajit, et al.. (2015). Antioxidant and Cytotoxic Activity of Different Extracts of Zanthoxylum Alatum. Free Radicals and Antioxidants. 5(1). 21–28. 14 indexed citations
10.
Karmakar, Indrajit, et al.. (2013). Antitumor activity and antioxidant property ofCurcuma caesiaagainst Ehrlich’s ascites carcinoma bearing mice. Pharmaceutical Biology. 51(6). 753–759. 37 indexed citations
11.
Kar, Biswakanth, et al.. (2013). Antitumor activity and antioxidant role of Streblus asper bark against Ehrlich ascites carcinoma in Swiss albino mice.. PubMed. 10(3). 197–202. 6 indexed citations
12.
Dolai, Narayan, et al.. (2012). Antitumor potential of Castanopsis indica (Roxb. ex Lindl.) A. DC. leaf extract against Ehrlich's ascites carcinoma cell.. PubMed. 50(5). 359–65. 16 indexed citations
13.
Dolai, Narayan, et al.. (2012). Evaluation of antitumor activity and in vivo antioxidant status of Anthocephalus cadamba on Ehrlich ascites carcinoma treated mice. Journal of Ethnopharmacology. 142(3). 865–870. 61 indexed citations
15.
Kar, Biswakanth, et al.. (2012). Antioxidant and in vitro anti-inflammatory activities of Mimusops elengi leaves. Asian Pacific Journal of Tropical Biomedicine. 2(2). S976–S980. 64 indexed citations
16.
Dolai, Narayan, et al.. (2012). Free radical scavenging activity of Castanopsis indica in mediating hepatoprotective activity of carbon tetrachloride intoxicated rats. Asian Pacific Journal of Tropical Biomedicine. 2(1). S243–S251. 31 indexed citations
17.
Kar, Biswakanth, et al.. (2012). Toxicity study of deflazacort on morphological development in zebrafish embryos. Comparative Clinical Pathology. 22(6). 1205–1210. 5 indexed citations
18.
Karmakar, Indrajit, et al.. (2011). Neuropharmacological assessment of Curcuma caesia rhizome in experimental animal models. Oriental Pharmacy and Experimental Medicine. 11(4). 251–255. 30 indexed citations
19.
Karmakar, Indrajit, et al.. (2011). Scavenging activity of Curcuma caesia rhizome against reactive oxygen and nitrogen species. Oriental Pharmacy and Experimental Medicine. 11(4). 221–228. 44 indexed citations
20.
Karmakar, Indrajit, Narayan Dolai, Asis Bala, & Pallab Kanti Haldar. (2011). AXIOLYTIC AD CS DEPRESSAT ACTIVITIES OF METHAOL EXTRACT OF CURCUMA CAESIA RHIZOME. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026